OBIO Orchestra BioMed Holdings, Inc.

NASDAQ
$7.46

Orchestra BioMed Holdings, Inc. (OBIO) is expected to report earnings on February 9, 2027, after the market close. The consensus earnings estimate is a loss of $0.37 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +29.7% since its last earnings release on November 10, 2026.

Orchestra BioMed Holdings, Inc. Beat Consensus Estimates
Tuesday, November 10, 2026 · 4:10 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 9
Tuesday · 4:10 PM ET
Earnings Whisper
-
vs ($0.37)
Rev est $120K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $6.87

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Orchestra BioMed Holdings, Inc.

Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.